Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Lloydspharmacy parent company appoints new CEO from Superdrug group

Lloydspharmacy's parent company, Celesio UK, has announced its new chief executive, Toby Anderson, will join the organisation in September.

Mr Anderson joins from the A.S. Watson Group – which includes Superdrug – where he held the role of CEO of Asia and eastern Europe, “with accountability for 1,500 pharmacies”, Celesio UK said this afternoon (May 2).

His 12-year career with A.S. Watson included country management roles, as well as marketing director for Asia and eastern Europe – “leading brand relaunches across 12 markets, including the introduction of new store formats, websites and loyalty programmes”, the multiple added.

Celesio UK confirmed to C+D that Mr Anderson replaces Cormac Tobin, who resigned from his managing director role at the company in November.

Brian Tyler, chairman of the management board of McKesson Europe – which owns Celesio UK – said: “Toby is committed to navigating the current and future challenges that our company faces and helping us to truly transform healthcare in the UK.”

What do you think of the appointment?

Related Content


Pharmacy Manager

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts